Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

The top 15 pharma companies by 2018 revenue
Fierce Pharma
Mon, 04/8/19 - 11:30 pm
Tags:
JNJ, Roche, Pfizer, Novartis, Merck, GSK, Sanofi, AbbVie, Bayer, Eli Lilly, Amgen, Bristol-Myers Squibb, Gilead Sciences, Teva Pharmaceutical, AstraZeneca
Big Pharma come together for better drug side effect detection
Pharma Times
Sun, 04/7/19 - 05:18 pm
Tags:
side effects, adverse events, Pfizer, Roche, Takeda, Eli Lilly, Bristol-Myers Squibb, Gilead Sciences, Alexion, Celgene, International Working Group on Signal Detection and Management in Pharmacovigilance, pharmacovigilance
Where Will Gilead Sciences Be in 5 Years? -- The Motley Fool
Motley Fool
Sun, 04/7/19 - 05:06 pm
Tags:
Gilead Sciences
Gilead sees Descovy as successor to Truvada for HIV PrEP
BioCentury
Fri, 04/5/19 - 11:39 pm
Tags:
Gilead Sciences, Descovy, Truvada, HIV, PrEP
Gilead earns needed trial win as arthritis drug succeeds in 2 studies
Biopharma Dive
Thu, 03/28/19 - 11:38 pm
Tags:
Gilead Sciences, filgotinib, clinical trials, FDA
Precision BioSciences Exceeds Expectations with IPO
CP Wire
Thu, 03/28/19 - 10:06 am
Tags:
Precision Biosciences, IPOs, Gilead Sciences
Thu, 03/28/19 - 09:39 am
Tags:
Precision Biosciences, IPOs, Gilead Sciences
Louisiana has picked its 'Netflix' hepatitis C partner: Gilead's new generics unit
Fierce Pharma
Wed, 03/27/19 - 11:45 am
Tags:
Louisiana, Gilead Sciences, hepatitis C, Asegua Therapeutics, Netflix model
Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25%
Motley Fool
Sun, 03/24/19 - 12:08 pm
Tags:
Gilead Sciences, GS-6207, HIV
Gilead raises prices on top-selling HIV treatments
Biopharma Dive
Tue, 03/19/19 - 10:34 am
Tags:
Gilead Sciences, drug pricing, HIV
New shareholder challenge to Gilead: What are you doing with billions in tax savings?
Bizjournals
Mon, 03/18/19 - 05:06 pm
Tags:
Gilead Sciences, taxes, tax reform
Gilead's Descovy snared its PrEP data, but can it stand up to Truvada generics?
Fierce Pharma
Wed, 03/13/19 - 04:39 pm
Tags:
Gilead Sciences, Truvada, PrEP, Descovy
Gilead shares early clinical data on HIV capsid inhibitor
Fierce Biotech
Fri, 03/8/19 - 11:35 am
Tags:
Gilead Sciences, HIV, GS-6207, clinical trials
Louisiana's 'Netflix' deal for hepatitis C drugs wins bids from AbbVie, Gilead and Merck
Fierce Pharma
Thu, 03/7/19 - 09:19 pm
Tags:
hepatitis C, AbbVie, Gilead Sciences, Louisiana, Netflix model
2 Biotech Stocks With Major Incoming Catalysts
Yahoo/Motley Fool
Thu, 03/7/19 - 09:52 am
Tags:
Axsome Therapeutics, AXS-05, depression, Galapagos, filgotinib, Gilead Sciences, rheumatoid arthritis
Gilead scores key HIV data as Descovy proves non-inferior to Truvada
BioPharma Dive
Wed, 03/6/19 - 08:13 pm
Tags:
Gilead Sciences, HIV, Descovy, Truvada, clinical trials
3 Big Pharmas Trying to Pop the Rebate Bubble
Motley Fool
Wed, 03/6/19 - 10:06 am
Tags:
drug pricing, drug rebates, Eli Lilly, Amgen, Gilead Sciences
Gilead oncology chief departing to head up Glenmark spin-out
Biopharma Dive
Wed, 03/6/19 - 12:37 am
Tags:
oncology, Alessandro Riva, Gilead Sciences, Glenmark
Top 10 drugs losing exclusivity in 2019
Fierce Pharma
Tue, 03/5/19 - 09:40 am
Tags:
market exclusivity, patents, Rituxan, Lyrica, Herceptin, Avastin, Epclusa, Harvoni, Pfizer, Roche, Gilead Sciences, Amgen, GSK, Allergan, Individor
Gilead’s Kite pens 10-target CAR-T tech deal with MaxCyte
Fierce Biotech
Sat, 03/2/19 - 12:42 pm
Tags:
Gilead Sciences, Kite Pharma, CAR-T, MaxCyte

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.